← Back to headlines
Medtronic's Cardiovascular and Diabetes Segments Show Strong Growth in FQ3
Medtronic's cardiovascular and diabetes divisions posted mid-teens growth in the third fiscal quarter, indicating strong performance in these key areas.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
